ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report)'s share price reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $9.50 and last traded at $9.17, with a volume of 1759980 shares. The stock had previously closed at $8.76.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group increased their price objective on ASP Isotopes from $8.50 to $11.00 and gave the company a "buy" rating in a research report on Wednesday, May 21st.
Get Our Latest Stock Report on ASPI
ASP Isotopes Stock Performance
The firm's 50-day moving average price is $6.22 and its two-hundred day moving average price is $5.48. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $698.60 million, a PE ratio of -15.26 and a beta of 3.56.
Insider Buying and Selling
In other news, CEO Paul Elliot Mann sold 316,667 shares of the stock in a transaction that occurred on Tuesday, April 15th. The shares were sold at an average price of $5.75, for a total value of $1,820,835.25. Following the completion of the sale, the chief executive officer now directly owns 7,948,787 shares of the company's stock, valued at $45,705,525.25. This represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Robert Ainscow sold 66,668 shares of ASP Isotopes stock in a transaction on Thursday, April 17th. The shares were sold at an average price of $5.62, for a total value of $374,674.16. Following the sale, the chief operating officer now directly owns 1,419,992 shares of the company's stock, valued at approximately $7,980,355.04. The trade was a 4.48% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 766,667 shares of company stock valued at $4,358,502. Company insiders own 21.40% of the company's stock.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of ASPI. Rhumbline Advisers lifted its holdings in shares of ASP Isotopes by 8.2% during the 1st quarter. Rhumbline Advisers now owns 65,326 shares of the company's stock valued at $306,000 after buying an additional 4,963 shares during the last quarter. Philadelphia Financial Management of San Francisco LLC lifted its stake in ASP Isotopes by 11.2% in the first quarter. Philadelphia Financial Management of San Francisco LLC now owns 3,508,062 shares of the company's stock valued at $16,453,000 after acquiring an additional 354,517 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in ASP Isotopes by 9.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company's stock worth $148,000 after acquiring an additional 2,709 shares in the last quarter. Bosun Asset Management LLC acquired a new position in shares of ASP Isotopes during the 1st quarter worth $103,000. Finally, AWM Investment Company Inc. increased its stake in shares of ASP Isotopes by 6.2% during the 1st quarter. AWM Investment Company Inc. now owns 4,511,186 shares of the company's stock worth $21,157,000 after purchasing an additional 265,000 shares during the last quarter. 16.80% of the stock is owned by institutional investors and hedge funds.
About ASP Isotopes
(
Get Free Report)
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ASP Isotopes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.
While ASP Isotopes currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
